Venus Concept (NASDAQ:VERO) Trading Down 3.2%

Venus Concept Inc. (NASDAQ:VERO) traded down 3.2% on Thursday . The company traded as low as $0.63 and last traded at $0.68. 83,012 shares were traded during trading, a decline of 91% from the average session volume of 913,324 shares. The stock had previously closed at $0.70.

Venus Concept Trading Up 4.7 %

The business has a 50-day simple moving average of $0.70 and a two-hundred day simple moving average of $0.82.

Venus Concept (NASDAQ:VERO) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($1.68) earnings per share for the quarter. The business had revenue of $17.48 million during the quarter. Equities analysts forecast that Venus Concept Inc. will post -4.66 EPS for the current year.

Insider Transactions at Venus Concept

In other news, major shareholder Michael Willingham Masters sold 102,717 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1.20, for a total transaction of $123,260.40. Following the completion of the sale, the insider now owns 383,345 shares in the company, valued at $460,014. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 51.39% of the company’s stock.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.